News from dendreon corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Aug 05, 2011, 04:45 ET Dendreon Announces Webcast Presentation at Canaccord Genuity Growth Conference

Dendreon Corporation (Nasdaq: DNDN) today announced that management will present at the Canaccord Genuity Growth Conference in Boston, MA on August...


Aug 03, 2011, 04:01 ET Dendreon Reports Second Quarter 2011 Financial Results

Dendreon Corporation (Nasdaq: DNDN) today reported results for the second quarter ended June 30, 2011. Net revenue for the quarter ended June 30,...


Jul 08, 2011, 08:30 ET Dendreon to Host Conference Call on August 3, 2011 to Announce Second Quarter 2011 Financial Results

Dendreon Corporation (Nasdaq: DNDN) today announced that management will host a conference call on Wednesday, August 3, 2011 at 4:30 p.m. ET to...


Jul 07, 2011, 12:37 ET Dendreon Announces Increased Capacity and Significant Reimbursement Decisions Supporting Broad Availability of PROVENGE

Dendreon Corporation (Nasdaq: DNDN) announced significant milestones that support broad availability for on-label use of PROVENGE® (sipuleucel-T),...


Jun 30, 2011, 04:47 ET Dendreon Announces Increased Capacity and Significant Reimbursement Decisions Supporting Broad Availability of PROVENGE

Dendreon Corporation (Nasdaq: DNDN) today announced significant milestones that support broad availability for on-label use of PROVENGE®...


Jun 29, 2011, 08:04 ET FDA Approves Dendreon's Los Angeles Cancer Immunotherapy Manufacturing Facility

Dendreon Corporation (Nasdaq: DNDN) today announced that the U.S. Food and Drug Administration (FDA) approved its Los Angeles cancer immunotherapy...


Jun 16, 2011, 06:00 ET Dendreon Announces Webcast Presentation at NASDAQ OMX 26th Investor Program

Dendreon Corporation (Nasdaq: DNDN) today announced that management will present at the NASDAQ OMX 26th Investor Program in London on June 21, 2011...


Jun 13, 2011, 06:32 ET Dendreon CEO Dr. Mitchell Gold Named Ernst & Young Entrepreneur Of The Year® 2011 Pacific Northwest Award Winner

Dendreon Corporation (Nasdaq: DNDN) today announced that Mitchell H. Gold, M.D., President and Chief Executive Officer received the Ernst & Young...


May 20, 2011, 06:00 ET Dendreon Announces Webcast Presentation at Upcoming Conferences

Dendreon Corporation (Nasdaq: DNDN) today announced that management will present at the following conferences: ThinkEquity Annual Healthcare...


May 18, 2011, 06:00 ET Dendreon Announces Clinical Trial Plans for PROVENGE and DN24-02 at the American Society of Clinical Oncology Annual Meeting

Dendreon Corporation (Nasdaq: DNDN) today announced three abstracts accepted for poster presentation detailing clinical trial plans for PROVENGE®...


May 18, 2011, 06:00 ET Dendreon Announces Presentation of PROVENGE Data at the 2011 American Society of Clinical Oncology Annual Meeting

Dendreon Corporation (Nasdaq: DNDN) today announced the following PROVENGE® (sipuleucel-T) data presentations taking place at the 2011 American...


May 02, 2011, 04:00 ET Dendreon Reports First Quarter 2011 Financial Results

Dendreon Corporation (Nasdaq: DNDN) today reported results for the first quarter ended March 31, 2011. Revenue for the quarter ended March 31, 2011...


Apr 28, 2011, 06:00 ET Dendreon Announces Webcast Presentations at Upcoming Conferences

Dendreon Corporation (Nasdaq: DNDN) today announced that management will present at the following conferences: Deutsche Bank Annual Health Care...


Apr 14, 2011, 06:00 ET Dendreon to Host Conference Call on May 2, 2011 to Announce First Quarter 2011 Financial Results

Dendreon Corporation (Nasdaq: DNDN) today announced that management will host a conference call on Monday, May 2, 2011 at 4:30 p.m. ET to review the...


Apr 06, 2011, 08:00 ET Dendreon Announces Presentation of Data at the American Association of Cancer Research Annual Meeting

Dendreon Corporation (Nasdaq: DNDN) today announced the following data presentations taking place at the American Association of Cancer Research...


Mar 30, 2011, 06:35 ET Dendreon Statement on CMS Proposed Decision Memo for PROVENGE®

Dendreon Corporation (Nasdaq: DNDN) announced today that the Centers for Medicare and Medicaid Services (CMS) has issued a proposed decision memo for ...


Mar 29, 2011, 06:00 ET Dendreon Announces Webcast Presentations at Upcoming Conferences

Dendreon Corporation (Nasdaq: DNDN) today announced that management will present at the following conferences: Needham Healthcare Conference, New...


Mar 10, 2011, 02:17 ET Dendreon Expands Launch of PROVENGE

Dendreon Corporation (Nasdaq: DNDN) announced today that the U.S. Food and Drug Administration (FDA) approved the remainder of its New Jersey...


Mar 01, 2011, 03:00 ET Dendreon Reports Fourth Quarter and 2010 Year End Financial Results

Dendreon Corporation (Nasdaq: DNDN) today reported results for the year and quarter ended December 31, 2010. Revenue for the year ended December 31,...


Feb 24, 2011, 06:00 ET Dendreon Announces Webcast Presentations at Four Upcoming Conferences

Dendreon Corporation (Nasdaq: DNDN) today announced that management will present at the following conferences: Citi Global Health Care Conference,...


Feb 17, 2011, 04:50 ET Dendreon Announces Presentation of PROVENGE Data at the 2011 Genitourinary Cancers Symposium Annual Meeting

Dendreon Corporation (Nasdaq: DNDN) today announced the following data presentations taking place at the 2011 Genitourinary Cancers Symposium annual...


Feb 08, 2011, 06:00 ET Dendreon to Host Conference Call on March 1st to Announce Fourth Quarter and Year-End Financial Results

Dendreon Corporation (Nasdaq: DNDN) today announced that management will host a conference call on Tuesday, March 1, 2011 at 4:30 p.m. ET to review...


Feb 03, 2011, 09:31 ET Dendreon Announces Exercise and Closing of Overallotment Option

Dendreon Corporation (Nasdaq: DNDN) today announced that the underwriter in its previously announced public offering of 2.875% convertible senior...


Jan 14, 2011, 11:13 ET Dendreon Announces Pricing of $540 Million Convertible Senior Notes Due 2016

Dendreon Corporation (Nasdaq: DNDN) today announced the pricing of a public offering of $540 million aggregate principal amount of 2.875% convertible ...


Jan 13, 2011, 04:10 ET Dendreon Announces Offering of $500 Million Convertible Senior Notes Due 2016

Dendreon Corporation (Nasdaq: DNDN) today announced its intention to offer, subject to market and other conditions, $500 million aggregate principal...